Speech-Language Pathologists in Lynn Haven, FL Accepting Medicare

15 Speech-Language Pathologists found. Showing 1 - 15

Suzannah Thompson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 W 26th St, Lynn Haven, FL 32444 Phone: 850-769-5371

April Siegel Asby Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 W 26th St, Lynn Haven, FL 32444 Phone: 850-769-5371    Fax: 850-872-9558

Kara Leigh Watford Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 W 26th St, Lynn Haven, FL 32444 Phone: 850-769-5371

Kyleigh Harris, M.ED.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Ashlee Way, Lynn Haven, FL 32444 Phone: 850-252-2034

Mrs. Andrea Brooke Long, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 W 26th St, Lynn Haven, FL 32444 Phone: 850-769-5371

Jinan Erchid Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 W 26th St, Lynn Haven, FL 32444 Phone: 850-769-5371

Language And Learning Time, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 406 Michigan Ave, Lynn Haven, FL 32444 Phone: 850-774-2313    Fax: 850-248-0447

Mrs. Lindsey Money, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3742 Bay Tree Rd, Lynn Haven, FL 32444 Phone: 850-258-5764

Lori E Fitzgerald, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 W 26th St, Lynn Haven, FL 32444 Phone: 850-769-5371

Marcia B Melzer, M.,ED.,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1419 Louisiana Ave, Lynn Haven, FL 32444 Phone: 850-303-4088    Fax: 850-248-9905

Wendi Wallace Jackson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 W 26th St, Lynn Haven, FL 32444 Phone: 850-769-5371

Charity Pongratz, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1213 Huntington Ridge Rd, Lynn Haven, FL 32444 Phone: 850-258-2363

Elizabeth Ashley, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 406 Michigan Ave, Lynn Haven, FL 32444 Phone: 850-571-5331

Lauren Sytsma, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 W 26th St, Lynn Haven, FL 32444 Phone: 850-769-5371    Fax: 850-872-9558

Mrs. Cassandra Ann Commander, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1322 Country Club Dr, Lynn Haven, FL 32444 Phone: 850-265-4400

News Archive

Study identifies metabolic factors related to bread's beneficial effects on cardiovascular health

According to a study, daily bread consumption, especially wholemeal bread, can prevent cardiovascular disease. The study has been led by the professor Rafael Llorach, Ramon y Cajal researcher from the Department of Nutrition and Bromatology at the Faculty of Pharmacy and from the Food and Nutrition Torribera campus of the University of Barcelona.

Endo International enters into definitive agreement to acquire Auxilium Pharmaceuticals

Endo International plc and Auxilium Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which Endo will acquire all of the outstanding shares of common stock of Auxilium for a per share consideration of $33.25 in a cash and stock transaction.

Bexarotene shows promise in cancer treatment.

Researchers at Washington University School of Medicine in St. Louis now report that a compound related to vitamin A shows promise in preventing or slowing tumor growth in mice prone to lung cancer. The compound, called bexarotene, doesn't cause the severe skin irritations that have limited the use of other vitamin A derivatives in cancer therapies.

Belgian FAMHP approves Oncolytics' Phase 3 combination trial of REOLYSIN in head and neck cancers

Oncolytics Biotech Inc. today announced that it has received approval from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that was agreed to by U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).

HHS limits Obamacare options for small businesses

A final rule released Friday confirms that a provision of the health law aimed at helping small businesses provide insurance to their employees will be limited until 2015.

Read more Medical News

› Verified 6 days ago